
Sisram Medical Ltd
HKEX:1696

Net Margin
Sisram Medical Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
IL |
![]() |
Sisram Medical Ltd
HKEX:1696
|
1.9B HKD |
7%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
230.4B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
194.9B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
154.8B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
145.1B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
108.3B USD |
13%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
54.3B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.6B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.8B USD |
75%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.4B USD |
23%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274.8B CNY |
31%
|
Sisram Medical Ltd
Glance View
Sisram Medical Ltd. is an investment holding company. The firm has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The firm's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The firm sells its products in domestic and foreign markets.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sisram Medical Ltd's most recent financial statements, the company has Net Margin of 7.2%.